Identification of nuclear matrix protein alterations associated with human colon cancer

Cancer Research

Volumn 62, Issue 8, 2002, Pages 2437-2442

  Brünagel, Gisela ^a   Vietmeier, Barbara N ^a   Bauer, Anthony J ^a   Schoen, Robert E ^a   Getzenberg, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL NUCLEUS MATRIX PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS MATRIX; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; COLON; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS;

EID: 0037089492     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Colon cancer
2. Cancer statistics, 2001
3. Fecal occult blood testing for colorectal cancer. Can we afford to do this?
4. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey
5. Major complications of coloscopy: Bleeding and perforation
6. Carcinoembryonic antigen in histopathology: Immunoperoxidase staining of conventional tissue sections
7. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?
8. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma
9. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer
10. OVXI and CEA in patients with colon carcinoma, colon polyps and benign colon disorders
11. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer
12. Carcinoembryonic antigen in patients with different cancers
13. Cancer as a disease of DNA organization and dynamic cell structure
14. Identification of a nuclear protein matrix
15. The nuclear matrix: Defining structural and functional roles
16. Nuclear matrix and the regulation of gene expression: Tissue specificity
17. The tissue matrix: Cell dynamics and hormone action
18. Change in the expression of a nuclear matrix-associated protein is correlated with cellular transformation
19. Interrelationships between nuclear structure and ligand-activated intracellular receptors
20. The nuclear matrix and apoptosis
21. Nuclear matrix proteins reflect cell type of origin in cultured human cells
22. Identification of nuclear matrix protein alterations associated with renal cell carcinoma
23. Bladder cancer-associated nuclear matrix proteins
24. Identification of nuclear matrix proteins in the cancer and normal rat prostate
25. Nuclear matrix proteins and their potential applications to diagnostic pathology
26. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4
27. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer
28. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck
29. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer
30. Nuclear matrix proteins in normal and breast cancer cells
31. Nuclear matrix proteins in human colon cancer
32. Detection of nuclear matrix proteins in serum from cancer patients
33. Development of a dedicated two-dimensional gel electrophoresis system that provides optimal pattern reproducibility and polypeptide resolution
34. Silver staining of proteins in polyacrylamide gels
35. New strategies in high sensitivity characterization of proteins separated from 1-D or 2-D
36. Office-based colonoscopy in a family practice
37. Nuclear matrix of calreticulin in hepatocellular carcinoma
38. Calreticulin is a receptor for nuclear matrix export